Cargando…

Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort study

BACKGROUND: Glucocorticoids are the mainstay of treatment for autoimmune blistering diseases (AIBDs). The Glucocorticoid Toxicity Index (GTI) is a novel, outcome-based glucocorticoid-induced adverse effects monitoring instrument. OBJECTIVE: To investigate whether the GTI score was able to accurately...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Yicong, Zeng, Faith A.P., Sheriff, Tabrez, Wilson, Anna, Bilgic, Asli, Feng, Grant, Stone, John H., Murrell, Dedee F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760348/ https://www.ncbi.nlm.nih.gov/pubmed/35059661 http://dx.doi.org/10.1016/j.jdin.2021.09.003

Ejemplares similares

Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
por: McDowell, P. Jane, et al.
Publicado: (2022)

Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study
por: Xie, Danica, et al.
Publicado: (2022)

Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review
por: Zeng, Faith A.P., et al.
Publicado: (2022)

Autoimmune blistering diseases in females: a review()()
por: Zhao, Cathy Y., et al.
Publicado: (2015)

Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases
por: Tseng, Henry, et al.
Publicado: (2023)

The effects of autoimmune blistering diseases on work productivity: A review()
por: Wang, Esther Q., et al.
Publicado: (2018)

Autoimmune blistering skin diseases triggered by COVID-19 vaccinations: An Australian case series
por: Cowan, Timothy L., et al.
Publicado: (2023)

T-Cell–Driven Fibroinflammation Inducing Follicular Dedifferentiation in Alopecia Areata and IgG4-Modified Disease
por: Kossard, Steven, et al.
Publicado: (2021)

The Role of Quantification of Glucocorticoid-associated Toxicity in Severe Asthma
por: McDowell, PJ, et al.
Publicado: (2021)

Multiple milia formation in blistering diseases
por: Patsatsi, Aikaterini, et al.
Publicado: (2020)

Conducting dermatology clinical trials during the COVID-19 pandemic
por: Sheriff, Tabrez, et al.
Publicado: (2021)

Editorial: Skin Blistering Diseases
por: Has, Cristina, et al.
Publicado: (2019)

Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
por: Flynn, Jacqueline K., et al.
Publicado: (2019)

Glucocorticoid Induced Cerebellar Toxicity in the Developing Neonate: Implications for Glucocorticoid Therapy during Bronchopulmonary Dysplasia
por: Noguchi, Kevin K.
Publicado: (2014)

GDF6 Knockdown in a Family with Multiple Synostosis Syndrome and Speech Impairment
por: Clarke, Raymond A., et al.
Publicado: (2021)

Protective effect of chlorpromazine on endotoxin toxicity and TNF production in glucocorticoid-sensitive and glucocorticoid-resistant models of endotoxic shock
Publicado: (1991)

Glucocorticoids in Freshwaters: Degradation by Solar Light and Environmental Toxicity of the Photoproducts
por: Cantalupi, Alice, et al.
Publicado: (2020)

Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
por: Bilgic-Temel, Aslı, et al.
Publicado: (2019)

Cutaneous leishmaniasis: A neglected disfiguring disease for women()()()
por: Bilgic-Temel, Asli, et al.
Publicado: (2019)

A Systematic Review of Drug-associated Bullous Pemphigoid
por: VERHEYDEN, Matthew J., et al.
Publicado: (2020)

A life for autoimmune blistering diseases: in memoriam Detlef Zillikens
por: Hundt, Jennifer E., et al.
Publicado: (2023)

Dexamethasone Therapy of Congenital Adrenal Hyperplasia and the Myth of the “Growth Toxic” Glucocorticoid
por: Rivkees, Scott A.
Publicado: (2010)

Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis
por: Palmowski, Andriko, et al.
Publicado: (2020)

Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial
por: Patel, Naomi J., et al.
Publicado: (2023)

Diagnosis of Autoimmune Blistering Diseases
por: Witte, Mareike, et al.
Publicado: (2018)

Editorial: Autoimmune Blistering Diseases
por: Kowalewski, Cezary, et al.
Publicado: (2020)

Role of Glucocorticoids and Glucocorticoid Receptors in Glaucoma Pathogenesis
por: Patel, Pinkal D., et al.
Publicado: (2023)

Dermatomyositis in patients with autoimmune blistering diseases()()
por: Patsatsi, Aikaterini, et al.
Publicado: (2019)

Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications
por: Karakioulaki, Meropi, et al.
Publicado: (2022)

Successful Combination Therapy with Rituximab and Glucocorticoids for Autoimmune Optic Neuropathy
por: Sasaki, Shoichi, et al.
Publicado: (2015)

Extra-adrenal glucocorticoid biosynthesis: Implications for autoimmune and inflammatory disorders.
por: Slominski, Radomir, et al.
Publicado: (2020)

Treatment of Statin-Induced Necrotizing Autoimmune Myopathy With Glucocorticoid Monotherapy
por: Lempel, Matthew, et al.
Publicado: (2020)

Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis
por: Sionov, Ronit Vogt, et al.
Publicado: (2006)

Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis
por: Sevilla, Lisa M., et al.
Publicado: (2019)

Bullous pemphigoid—What do we know about the most recent therapies?
por: Zeng, Faith A. P., et al.
Publicado: (2022)

Glucocorticoids in Sepsis: To Be or Not to Be
por: Vandewalle, Jolien, et al.
Publicado: (2020)

Interaction of glucocorticoids with macrophages. Identification of glucocorticoid receptors in monocytes and macrophages
Publicado: (1978)

Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β
por: Leung, Donald Y.M., et al.
Publicado: (1997)

Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease
por: Migita, Kiyoshi, et al.
Publicado: (2013)

Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison’s Disease
por: Sævik, Åse Bjorvatn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2h8qlgd4lujv0cto6b4caarjpd